BIOMX INC's ticker is PHGE and the CUSIP is 09090D103. A total of 15 filers reported holding BIOMX INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $750,958 | -2.2% | 2,133,402 | 0.0% | 0.28% | +16.4% |
| Q2 2023 | $768,025 | +18.0% | 2,133,402 | 0.0% | 0.24% | +12.3% |
| Q1 2023 | $650,688 | +163389.4% | 2,133,402 | 0.0% | 0.21% | +82.8% |
| Q4 2022 | $398 | -99.9% | 2,133,402 | 0.0% | 0.12% | -45.5% |
| Q3 2022 | $725,000 | -53.4% | 2,133,402 | 0.0% | 0.21% | -46.5% |
| Q2 2022 | $1,557,000 | -62.2% | 2,133,402 | 0.0% | 0.40% | -48.8% |
| Q1 2022 | $4,117,000 | +20.6% | 2,133,402 | 0.0% | 0.78% | +100.0% |
| Q4 2021 | $3,413,000 | -47.7% | 2,133,402 | 0.0% | 0.39% | -32.1% |
| Q3 2021 | $6,528,000 | – | 2,133,402 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 2,133,402 | $11,648,000 | 1.19% |
| MMCAP International Inc. SPC | 684,451 | $3,737,000 | 0.18% |
| Orbimed Advisors | 2,313,489 | $12,632,000 | 0.13% |
| Taylor Wealth Management Partners | 31,804 | $174,000 | 0.06% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 14,207 | $78,000 | 0.04% |
| ROYCE & ASSOCIATES LP | 359,000 | $1,960,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 104,000 | $568,000 | 0.01% |
| J. Goldman & Co LP | 150,000 | $92,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 427,702 | $2,335,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,060 | $6,000 | 0.00% |